Development of diagnostic methods for toxoplasmosis and molecular phylogenetic analysis of Toxoplasma gondii

Phase 1

Recruiting

• Conditions: toxoplasmosis; Toxoplasma gondii, toxoplasmosis, congenital, acquired; D014123

• Registration Number: JPRN-jRCT1030230328
• Lead Sponsor: orose Kazumi

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-09-05
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 520

Inclusion Criteria

Patients who are suspected of having toxoplasmosis and have requested toxoplasmosis PCR diagnosis from medical facilities across the country will be asked to use the remaining samples/DNA after PCR diagnosis, and patients who have consented will be targeted. The age, gender, inpatient/outpatient status, detailed disease classification, pretreatment regulations, etc. of the target patient are not considered. (including minors)

Exclusion Criteria

Pretreatment regulations, medical past history, complications, laboratory test data, etc. of the target patients are not considered.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
tokisoplasma antibody titer